Skip to main content
SpringerLink
Log in

Alemtuzumab/probenecid

Autoimmune haemolytic anaemia and pure red cell aplasia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kako S, Kanda Y, Oshima K, Nishimoto N, Sato H, Watanabe T, Hosoya N, Motokura T, Miyakoshi S, Taniguchi S, Kamijo A, Takahashi K, Chiba S, Kurokawa M.Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. American Journal of Hematology 83: 247-249, No. 3, Mar 2008 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alemtuzumab/probenecid. React. Wkly. 1197, 5 (2008). https://doi.org/10.2165/00128415-200811970-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811970-00012

Keywords

Search

Navigation